Tag Archives: Psychedelics

Rafael Lancelotta – 5-MeO-DMT Use in the Global Population

Full talk title: 5-MeO-DMT Use in the Global Population: Insights and Perspectives for Further Clinical Development Psychedelic medicines are increasingly being investigated as potential adjuncts to psychotherapy. They have shown great promise in the treatment of various mental health disorders, including post-traumatic stress disorder (PTSD), treatment-resistant depression, and anxiety-related disorders. Although psychedelic and psychedelic-like drugs… Read More »

MAPS Founder Rick Doblin on Psychedelics and Treating PTSD with MDMA

Optimal Performance Podcast #68: MAPS Founder Rick Doblin on Psychedelics and MDMA for PTSD Boost Your Mood With a FREE Bottle of Serotonin Brain Food https://naturalstacks.iljmp.com/4/freeserotonin More Than CBD https://naturalstacks.iljmp.com/4/cbd Which Natural Stacks Supplements Are Right For You? https://naturalstacks.iljmp.com/4/quiz Source: Youtube

Psychedelic Neuroscience – Ayahuasca for PTSD, Part 1: Lecture

This was a public lecture at the University of Minnesota Twin Cities campus for the public group, https://www.meetup.com/Psychedelic-Neuroscience/events/263601977/. The topic is the rising popularity of ayahuasca to treat PTSD. Professor Nielson will present data from her ongoing anonymous online survey study of ayahuasca use in naturalistic settings, with special focus on participants seeking out treatment… Read More »

Psychedelics Enhance Neural Plasticity in Rats: Supports Use for Mental Health Treatment

Increased brain plasticity in rats due to psychedelics supports evidence for future use in treating mental health disorders such as depression, anxiety, addiction, and post-traumatic stress disorder. Twitter: Tweets by TheChrisCortex Facebook: https://www.facebook.com/TheChrisCortex Article: https://medicalxpress.com/news/2018-06-psychedelic-drugs-neural-plasticity-rats.html Source: Youtube

#SSDP2019 – Psychedelic Medicine and Political Activism with Rick Doblin

This talk from Rick Doblin, Ph.D. (MAPS) will focus on the status of research to develop MDMA- assisted psychotherapy into an FDA-approved prescription medicine for posttraumatic stress disorder (PTSD), the overall progress in mainstreaming psychedelics and psychedelic experiences, and how these developments in science and medicine have been influenced by political pressures related to drug… Read More »

What are Three Categories of Psychedelic Drugs?

Psychedelic drugs are a subcategory of hallucinogens and can be classified into three main categories: Serotonergic (classical psychedelic drugs) – these are usually what the layman (or woman) thinks of when they conjure up an idea of psychedelic drugs. LSD, DMT, and mescaline all fall into this category. Using these drugs will cause drastic changes… Read More »

Horizons 2016: JESSICA L. NIELSON, Ph.D. "Ayahuasca for PTSD"

“Ayahuasca for PTSD: Assessing Benefits and Risks Through Multiple Perspectives” SYNOPSIS: With the increased notoriety of Ayahuasca in the western world to treat a variety of disorders, including addiction, depression and post-traumatic stress disorder (PTSD), it is important to gather evidence regarding potential risks and benefits that this powerful traditional medicine may offer for such… Read More »

Michael Mithoefer MDMA/PTSD Special Segment from CNN

Help us caption and translate this video on Amara.org: http://www.amara.org/en/v/Bp7O/ This two-minute cable television news segment was broadcast the day Dr. Mithoefer presented the findings of the MAPS MDMA/PTSD pilot study at the International Society for Traumatic Studies conference. Gail Westerfeld, one of Mithoefers Subjects, told CNN that she has been without nightmares for four… Read More »

Psychedelics: Treating Addiction, Depression and Anxiety with Dr. Roland Griffiths

Psychedelics were the subject of serious medical research in the 1940s to the 1960s, when many scientists believed some of the mind-bending compounds held tremendous therapeutic promise for treating a number of conditions including severe mental health problems and alcohol addiction. By the mid-60s, research into psychedelics was shut down for decades. After the blackout… Read More »

The Soulspace Podcast Episode 15: From Ecstasy to Remedy – MDMA Therapy with Anne Wagner

In 2017, the FDA granted “Breakthrough Therapy” Designation to MDMA for the treatment of post-traumatic stress disorder (PTSD) and is currently in phase 3 clinical trials. Popularly known as a recreational drug, and as the main ingredient in ecstasy, MDMA is paving the way for the possible near-term legalization of psychedelic therapy. On this episode,… Read More »

A Harvard Student on Psychedelic Drugs

Hi, my name is Andrew Zuckerman, I’m a student at Harvard University studying computer science. And in this video, I talk about psychedelic drugs. facebook.com/andzuck instagram.com/andzuck GENERAL RESOURCES Michael Pollan’s book, “How to Change Your Mind”: https://michaelpollan.com/books/how-to-change-your-mind/ Johns Hopkins: https://hopkinspsychedelic.org/ Imperial College London: https://www.imperial.ac.uk/department-of-medicine/research/brain-sciences/psychiatry/psychedelics/ MAPS: https://maps.org/ Enthea: https://www.enthea.net/ Psychonaut Wiki: https://psychonautwiki.org/ Qualia Computing: https://qualiacomputing.com/ The… Read More »

Psychedelics & PTSD: What’s the Deal? – Doctor Speaks His Mind.

Psychedelic drugs (eg, LSD, MDMD, Ketamine, DMT, Psilocybin, etc.) are popular recreational substances, but do they have any medical value? Research has been done, but there is a lot of myths and misunderstanding on both sides of the argument. In this video, Dr. Woods gives a clinical physician’s view on these controversial chemicals and their… Read More »